On December 6, 2019, the board of directors of Artelo Biosciences, Inc. appointed John W. Beck to the Board, effective immediately, with a term expiring at the Company’s 2020 annual meeting of stockholders. Mr. Beck will also serve as the Chair of the audit committee of the Board. Mr. Beck, age 59, has served as the Senior Vice President and Chief Financial Officer at Ritter Pharmaceuticals, Inc. since May 2018. From 2008 until its acquisition by AstraZeneca in 2012, Mr. Beck, served first as a board member and later as Chief Financial Officer and Senior Vice President of finance & operations of Ardea Biosciences Inc. Before joining Ardea, Mr. Beck spent 10 years with Metabasis Thereapeutics Inc., as a Co-Founder and its Chief Financial Officer. On December 2, 2019, Georgia Erbez resigned from the Board effective immediately. Ms. Erbez’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.